Counterpoint Mutual Funds’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$675K Sell
42,537
-333,201
-89% -$5.16M 0.07% 123
2026
Q1
$5.08M Buy
375,738
+146,742
+64% +$2.05M 0.76% 8
2025
Q4
$2.85M Buy
+228,996
New +$2.47M 0.21% 55

Other funds holding VTRS

Counterpoint Mutual Funds's VTRS Position: Q2 2026 in Review

Counterpoint Mutual Funds reduced its Viatris (VTRS) stake by 89% in Q2 2026, selling an estimated $5.16M and leaving 42,537 shares worth $675K. The position accounts for 0.07% of the portfolio, ranked #123.

Counterpoint Mutual Funds first reported a position in VTRS in Q4 2025 and has held it in 3 quarters since. The position peaked at $5.08M in Q1 2026. 1,028 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Counterpoint Mutual Funds held 42,537 shares of Viatris worth $675K as of Q2 2026.
  • Counterpoint Mutual Funds sold 333,201 Viatris shares in Q2 2026, an estimated $5.16M.
  • Viatris made up 0.07% of Counterpoint Mutual Funds's portfolio in Q2 2026, its #123 holding.
  • Counterpoint Mutual Funds first reported a position in Viatris in Q4 2025 and has held it in 3 quarters since.
  • Counterpoint Mutual Funds's Viatris position peaked at $5.08M in Q1 2026.
  • 1,028 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Counterpoint Mutual Funds's 13F filing for Q2 2026, filed 20 Jul 2026.